Preeclampsia (PE) remains a major challenge in obstetric care, often leading to severe maternal and neonatal complications. While clinicians frequently prescribe Aspirin in Preeclampsia for prevention, the exact molecular pathways behind its success have remained partially hidden. However, a groundbreaking study published in Reproductive Biology has recently identified a critical mechanism involving the NRF2 signaling pathway.

Researchers examined placental tissues from patients with normotensive pregnancies alongside those with mild and severe preeclampsia. They observed that severe preeclampsia cases consistently showed heightened oxidative stress and weakened antioxidant defenses. To understand this further, the team exposed trophoblast cells to hypoxic conditions in a laboratory setting. These cells showed significant impairment in proliferation and invasion, which are essential processes for healthy placental development. Notably, aspirin treatment successfully reversed these impairments by reducing reactive oxygen species (ROS) and apoptosis.

Mechanism of Aspirin in Preeclampsia and NRF2 Activation

The study highlights Nuclear factor erythroid 2-related factor 2 (NRF2) as the central regulator of this protective effect. Aspirin actively triggers the NRF2 pathway, which subsequently upregulates the body's internal antioxidant enzymes. This process neutralizes harmful oxidative stress caused by placental hypoxia. Furthermore, the researchers utilized genetic silencing techniques to verify these findings. When they knocked down NRF2, the cytoprotective and antioxidative benefits of aspirin almost entirely vanished. Consequently, this proves that the drug’s efficacy relies heavily on this specific signaling pathway.

Moreover, these findings offer a robust scientific foundation for the clinical use of low-dose aspirin. By maintaining trophoblast function, aspirin ensures that the placenta can adapt to stressful environments. This is particularly relevant in countries like India, where early screening and intervention for high-risk pregnancies are vital. Therefore, understanding this NRF2-dependent mechanism helps physicians better appreciate the long-term benefits of early aspirin therapy in preventing placental dysfunction.

Frequently Asked Questions

How does aspirin help prevent preeclampsia?

Aspirin activates the NRF2 signaling pathway, which boosts the production of antioxidant enzymes. This protects placental trophoblast cells from damage caused by low oxygen levels and oxidative stress.

What is the role of NRF2 in pregnancy?

NRF2 acts as a master regulator of the cellular antioxidant defense. In pregnancy, it helps the placenta survive oxidative injuries, ensuring proper growth and function of trophoblast cells.

Why is trophoblast invasion important?

Proper trophoblast invasion is necessary for remodeling the mother’s blood vessels to supply the fetus. If this process fails, it leads to the hypoxia and hypertension characteristic of preeclampsia.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Wu J et al. Aspirin protects trophoblast function against hypoxia-induced oxidative stress through activation of NRF2 signaling in preeclampsia. Reprod Biol. 2026 Jun 04. doi: undefined. PMID: 42241790.

2. Federation of Obstetric and Gynaecological Societies of India (FOGSI). Hypertensive Disorders of Pregnancy Guidelines. 2023.

3. Kupka E. Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps. Am J Obstet Gynecol Glob Rep. 2024.